Effect of vaccine Vacc-4x, romidepsin and neutralizing antibody (bNAB), in HIV-1 infections
Latest Information Update: 04 Apr 2017
At a glance
- Drugs Vacc-4x (Primary) ; Antibodies; Romidepsin
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms BIONAB
- 27 Jan 2017 According to a Bionor media release, the Research Council of Norway (RCN) through its BIA Program (Brukerstyrt Innovasjonsarena), has awarded the company up to NOK 10.3 million to partially fund this exploratory trial.
- 02 Oct 2016 New trial record